Thu, Apr 18, 2024
[Archive]
Volume 11, Issue 1 ( March 2019 2019)
Iranian Journal of Blood and Cancer 2019, 11(1): 33-35 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ansari Damavandi S, Ashayeri N. BK Virus-Associated Hemorrhagic Cystitis in Children Suffering from Malignancies: Report of Three Cases. Iranian Journal of Blood and Cancer 2019; 11 (1) :33-35
URL: http://ijbc.ir/article-1-840-en.html
URL: http://ijbc.ir/article-1-840-en.html
1- Department of Hematology-Oncology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, IR
2- Department of Hematology-Oncology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, IR , neda_ashayeri@yahoo.com
2- Department of Hematology-Oncology, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, IR , neda_ashayeri@yahoo.com
Abstract: (3457 Views)
BK virus-associated hemorrhagic cystitis (HC) is frequent in patients undergoing bone marrow transplantation, but it rarely occurs among other immunosuppressed patients particularly in those who are receiving chemotherapy for hematologic malignancies. Herein, we report three children with malignancies suffering from hemorrhagic cystitis due to BK virus infection who were successfully improved.
Early detection of BK virus using RT-PCR technique was undertaken. With administration of antiviral agents; specifically, IVIG or leflunomide, BK virus-associated HC could be successfully managed in children affected by malignancies and consequently, chemotherapy of underlying disorder might be continued after virus elimination.
Early detection of BK virus using RT-PCR technique was undertaken. With administration of antiviral agents; specifically, IVIG or leflunomide, BK virus-associated HC could be successfully managed in children affected by malignancies and consequently, chemotherapy of underlying disorder might be continued after virus elimination.
: Case report |
Subject:
Pediatric Hematology & Oncology
Received: 2018/10/8 | Accepted: 2019/02/25 | Published: 2019/03/15
Received: 2018/10/8 | Accepted: 2019/02/25 | Published: 2019/03/15
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
